Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

Name: Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
Published: 2023
License: Public Domain

AbbVie · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

cancer

diffuse large b-cell lymphoma, chronic lymphocytic leukemia, b cell malignancies, non-hodgkin's lymphoma, b-cell malignancies, abbv-525, cancer, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

Related documents